Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sahena Haque

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Rheumatology|February 3, 2012
Construct and criterion validity of the short form-6D utility measure in patients with systemic lupus erythematosusMark J Harrison, Yasmeen Ahmad, Sahena Haque, et al.
Rheumatology (Oxford, England)|December 19, 2022
Determinants of health-related quality of life across the spectrum of connective tissue diseases using latent profile analysis: results from the LEAP cohortSarah Dyball, John A Reynolds, Ariane L Herrick, et al.
Arthritis and Rheumatism|February 13, 2013
Shortened telomere length in patients with systemic lupus erythematosusSahena Haque, Chadi Rakieh, Fiona Marriage, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 20, 2012
Limited end-user knowledge of methotrexate despite patient education: an assessment of rheumatologic preventive practice and effectivenessEvin Sowden, Wajid Hassan, Ann Gooden, et al.
Arthritis Research & Therapy|August 11, 2018
Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulationsJohn A Reynolds, Eoghan M McCarthy, Sahena Haque, et al.
Seminars in Arthritis and Rheumatism|May 26, 2024
Clinical trial eligibility of a real-world connective tissue disease cohort: Results from the LEAP cohortSarah Dyball, Anastasia-Vasiliki Madenidou, Mia Rodziewicz, et al.
Arthritis Research & Therapy|June 16, 2019
Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profilesJohn A Reynolds, Tracy A Briggs, Gillian I Rice, et al.
The Journal of Rheumatology|December 4, 2009
Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) studySahena Haque, Caroline Gordon, David Isenberg, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Rheumatology|February 3, 2012
Construct and criterion validity of the short form-6D utility measure in patients with systemic lupus erythematosusMark J Harrison, Yasmeen Ahmad, Sahena Haque, et al.
Rheumatology (Oxford, England)|December 19, 2022
Determinants of health-related quality of life across the spectrum of connective tissue diseases using latent profile analysis: results from the LEAP cohortSarah Dyball, John A Reynolds, Ariane L Herrick, et al.
Arthritis and Rheumatism|February 13, 2013
Shortened telomere length in patients with systemic lupus erythematosusSahena Haque, Chadi Rakieh, Fiona Marriage, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 20, 2012
Limited end-user knowledge of methotrexate despite patient education: an assessment of rheumatologic preventive practice and effectivenessEvin Sowden, Wajid Hassan, Ann Gooden, et al.
Arthritis Research & Therapy|August 11, 2018
Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulationsJohn A Reynolds, Eoghan M McCarthy, Sahena Haque, et al.
Seminars in Arthritis and Rheumatism|May 26, 2024
Clinical trial eligibility of a real-world connective tissue disease cohort: Results from the LEAP cohortSarah Dyball, Anastasia-Vasiliki Madenidou, Mia Rodziewicz, et al.
Arthritis Research & Therapy|June 16, 2019
Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profilesJohn A Reynolds, Tracy A Briggs, Gillian I Rice, et al.
The Journal of Rheumatology|December 4, 2009
Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) studySahena Haque, Caroline Gordon, David Isenberg, et al.
Pageof 2